NCT00307489View on ClinicalTrials.gov

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

PHASE2CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

October 31, 2010

Conditions

Chronic Hepatitis B

Interventions

DRUG

tenofovir DF

300 mg tablet, once daily (QD)

DRUG

emtricitabine /tenofovir DF

emtricitabine 200 mg/tenofovir DF 300 mg once daily (combination tablet)

Trial Locations (28)

10013

New York

10016

New York

10021

New York

10969

Berlin

11355

Flushing

13285

Marseille

13353

Berlin

19107

Philadelphia

20999

Hamburg

22031

Fairfax

23249

Richmond

23502

Norfolk

30623

Hanover

41014

Seville

44623

Herne

45122

Essen

49933

Angers

53105

Bonn

59037

Lille

60590

Frankfurt

67091

Strasbourg

69288

Lyon

76031

Rouen

81377

München

91054

Erlangen

92110

Clichy

94115

San Francisco

95128

San Jose

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY